Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
6,870.00    115.00 (1.70%)
Bid:
6,855.00
Ask:
6,860.00
Spread: 5.00 (0.073%)
Market Cap: £30.42b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Transaction in Own Shares

16 Mar 2020 18:00

RNS Number : 3603G
Coca-Cola European Partners plc
16 March 2020
 

16 March 2020

 

COCA-COLA EUROPEAN PARTNERS PLC

(the "Company")

 

Transactions in Own Shares

 

The Company announces that it has purchased the following number of its ordinary shares of EUR 0.01 each through Credit Suisse Securities (USA) LLC. The purchased shares have all been cancelled.

 

These share purchases form part of the Company's existing buyback programme, as announced on 13 February 2020, in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 29 May 2019 (the "Buyback Programme"). The Company will make further announcements in due course following the completion of any further purchases pursuant to the Buyback Programme.

 

USX purchases

 

Daily aggregated information by trading venue

 

Date of purchase

Aggregate number of ordinary shares of EUR 0.01 each purchased

Lowest price paid per share (USX)

Highest price paid per share (USX)

Volume weighted average price paid per share (USX)

Trading venue

9 March 2020

117,000

 

48.63

51.52

49.991835

 

New York Stock Exchange ("NYSE")

10 March 2020

121,000

47.34

49.85

48.618016

NYSE

11 March 2020

125,000

45.59

48.25

46.966190

NYSE

12 March 2020

152,000

39.64

42.65

40.783424

NYSE

13 March 2020

148,479

40.23

43.33

41.776429

NYSE

13 March 2020

521

43.24

43.24

43.240000

BATS Global Markets, Inc. ("BATS")

 

Transaction details

 

The table below contains detailed information of the individual USX trades made by Credit Suisse Securities (USA) LLC as part of the Buyback Programme.

 

Schedule of purchases

 

Shares purchased:

Coca-Cola European Partners plc, (ISIN: GB00BDCPN049)

Dates of purchases:

9, 10, 11, 12 and 13 March 2020

Investment firm:

Credit Suisse Securities (USA) LLC

 

Individual transactions

 

A full breakdown of the individual transactions can be viewed at:

https://www.cocacolaep.com/assets/Governance_docs/Buyback-Announcements/0412cccbeb/200316-Weekly-Buyback-Programme_indiv-trade-details.pdf

 

COCA-COLA EUROPEAN PARTNERS PLC

Paul van Reesch

Deputy Company Secretary

+44 (0) 1895 231 313

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSDQLFFBXLXBBB
Date   Source Headline
12th Dec 20244:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20242:45 pmRNSTotal Voting Rights
21st Nov 202411:00 amRNSDirector/PDMR Shareholding
18th Nov 20242:00 pmRNSUpdate statement on 2024 AGM voting results
15th Nov 20248:01 amRNSTransfer to ESCC Category
5th Nov 20243:30 pmRNSDirector/PDMR Shareholding
5th Nov 20247:00 amRNSQ3 Trading Update & Interim Dividend Declaration
1st Nov 20241:31 pmRNSTotal Voting Rights
24th Oct 20243:30 pmRNSDirector/PDMR Shareholding
22nd Oct 20243:00 pmRNSDirector/PDMR Shareholding
18th Oct 20247:00 amRNSIntention to Transfer to ESCC Category
1st Oct 20241:00 pmRNSTotal Voting Rights
25th Sep 202412:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20243:30 pmRNSDirector/PDMR Shareholding
18th Sep 20243:30 pmRNSDirector/PDMR Shareholding
18th Sep 20243:30 pmRNSBlock listing Interim Review
10th Sep 20244:00 pmRNSDirector/PDMR Shareholding
6th Sep 20244:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20242:00 pmRNSTotal Voting Rights
27th Aug 202411:13 amRNSDirector/PDMR Shareholding
20th Aug 20242:30 pmRNSDirector/PDMR Shareholding
7th Aug 20247:00 amRNSResults for the six months ended 28 June 2024
1st Aug 20242:00 pmRNSTotal Voting Rights
24th Jul 20241:30 pmRNSDirector/PDMR Shareholding
22nd Jul 20241:30 pmRNSDirector/PDMR Shareholding
17th Jul 202412:15 pmRNSDirector/PDMR Shareholding
1st Jul 20241:45 pmRNSTotal Voting Rights
21st Jun 20241:00 pmRNSDirector/PDMR Shareholding
5th Jun 20245:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20242:45 pmRNSTotal Voting Rights
28th May 20241:15 pmRNSDirector/PDMR Shareholding
23rd May 20247:00 amRNSAppointment of Chief Financial Officer
22nd May 20244:02 pmRNSResult of AGM
21st May 20241:30 pmRNSDirector/PDMR Shareholding
10th May 20247:00 amRNSLetter to Shareholders
3rd May 20247:00 amRNSResignation of Chief Financial Officer
1st May 20243:00 pmRNSTotal Voting Rights
25th Apr 20247:00 amRNSQ1 Trading Update & Interim Dividend Declaration
24th Apr 20241:30 pmRNSDirector/PDMR Shareholding
17th Apr 20241:45 pmRNSDirector/PDMR Shareholding
10th Apr 20249:15 amRNSNotice of AGM
2nd Apr 20242:30 pmRNSTotal Voting Rights
21st Mar 20242:00 pmRNSDirector/PDMR Shareholding
20th Mar 20243:00 pmRNSDirector/PDMR Shareholding
18th Mar 20244:30 pmRNSBlock listing Interim Review
15th Mar 202411:59 amRNSAnnual Financial Report
1st Mar 20242:00 pmRNSTotal Voting Rights
23rd Feb 20247:00 amRNSCompletion of joint acquisition of CCBPI
23rd Feb 20247:00 amRNSPreliminary Unaudited Results Q4 & FY 2023
21st Feb 20245:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.